Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Hohenstein

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|February 22, 2021
Solid organ transplantation is not a risk factor for COVID-19 disease outcomeChristian Hugo, Melanie Stecher, Sebastian Dolff, et al.
American Journal of Physiology. Renal Physiology|March 19, 2010
Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidneyBernd Hohenstein, Mei-Chuan Kuo, Francesco Addabbo, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?Franz Heigl, Tobias Pflederer, Reinhard Klingel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2014
Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomyRoman N Rodionov, Jens Martens-Lobenhoffer, Silke Brilloff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2015
Acetylation of asymmetric and symmetric dimethylarginine: an undercharacterized pathway of metabolism of endogenous methylargininesRoman N Rodionov, Jens Martens-Lobenhoffer, Silke Brilloff, et al.
Biochemical and Biophysical Research Communications|November 17, 2012
In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in miceAnja Kittel, Renke Maas, Jörg König, et al.
Blood Purification|March 20, 2020
Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration PlasmapheresisClemens Grupp, Johannes Beckermann, Eric Köster, et al.
Acta Cardiologica|April 24, 2025
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS studyKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Atherosclerosis. Supplements|November 4, 2017
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathyRoman N Rodionov, Annett Heinrich, Silke Brilloff, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 4, 2025
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodiesKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Transplant International : Official Journal of the European Society for Organ Transplantation|February 22, 2021
Solid organ transplantation is not a risk factor for COVID-19 disease outcomeChristian Hugo, Melanie Stecher, Sebastian Dolff, et al.
American Journal of Physiology. Renal Physiology|March 19, 2010
Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidneyBernd Hohenstein, Mei-Chuan Kuo, Francesco Addabbo, et al.
Atherosclerosis. Supplements|December 11, 2019
Lipoprotein apheresis in Germany - Still more commonly indicated than implemented. How can patients in need access therapy?Franz Heigl, Tobias Pflederer, Reinhard Klingel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2014
Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomyRoman N Rodionov, Jens Martens-Lobenhoffer, Silke Brilloff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2015
Acetylation of asymmetric and symmetric dimethylarginine: an undercharacterized pathway of metabolism of endogenous methylargininesRoman N Rodionov, Jens Martens-Lobenhoffer, Silke Brilloff, et al.
Biochemical and Biophysical Research Communications|November 17, 2012
In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in miceAnja Kittel, Renke Maas, Jörg König, et al.
Blood Purification|March 20, 2020
Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration PlasmapheresisClemens Grupp, Johannes Beckermann, Eric Köster, et al.
Acta Cardiologica|April 24, 2025
Determinants of lipid lowering therapy intensification in very high risk patients with dyslipidaemia eligible for PCSK9 monoclonal antibodies: 1-year outcomes of the PERI-DYS studyKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Atherosclerosis. Supplements|November 4, 2017
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathyRoman N Rodionov, Annett Heinrich, Silke Brilloff, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 4, 2025
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodiesKlaus G Parhofer, David Pittrow, Andreas L Birkenfeld, et al.
Pageof 7